Sign inJoin waitlistJoin the waitlist

SC

Samuel Cytryn

Assistant Attending Physician · New York Presbyterian Hospital

Credentials: · · · ·

History

Memorial Sloan Kettering Westchester · Memorial Hospital for Cancer and allied Diseases
2024–Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
2021–2024
Internal Medicine
NYU Grossman School of Medicine
2017–2020
Icahn School of Medicine at Mount Sinai
2013–2017

Research

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2…
The Lancet Oncology · 2023 · First of 30 authors · 43 citations
PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays
JCO Precision Oncology · 2024 · 38 citations
Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid Arthritis
Journal of clinical rheumatology · 2021 · 34 citations

YJ
Yelena Janjigian
6 papers
GK
Geoffrey Ku
3 papers
Jun Mao
3 papers
LT
Laura Tang
3 papers
SM
Steven Maron
3 papers
Abraham Chachoua
2 papers
Anna Pavlick
2 papers
DM
Daniela Molena
2 papers
DI
David Ilson
2 papers
DJ
David Jones
2 papers
David Solit
2 papers
EE
Elizaveta Efuni
2 papers · 1 as a resident

Clinical trials

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Principal investigator · Recruiting · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2026–2029